Open Access Highly Accessed Research article

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Loukas F Kontovinis123, Konstantinos T Papazisis12*, Panagiota Touplikioti2, Charalambos Andreadis1, Despoina Mouratidou1 and Alexandros H Kortsaris3

Author Affiliations

1 3rd Department of Medical Oncology, Theagenion Cancer Hospital, Al Simeonidi str. 2, 54007, Thessaloniki, Greece

2 Applied Molecular Oncology Laboratory, Theagenion Cancer Hospital, Al Simeonidi str. 2, 54007, Thessaloniki, Greece

3 Laboratory of biochemistry, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece

For all author emails, please log on.

BMC Cancer 2009, 9:82  doi:10.1186/1471-2407-9-82

Published: 12 March 2009

Additional files

Additional file 1:

Mean plasma values of angiogenesis markers in patients that progressed (PD) or had a clinical benefit (CB) on evaluation after two cycles of treatment.

Format: DOC Size: 44KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data